Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namodenoson in Chronic Hepatitis C Genotype 1
NCT00790673Phase 2Completed
- Sponsor
- Can-Fite BioPharma Ltd.
- Start
- Jul 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of namodenoson in hepatitis C (HCV), sponsored by Can-Fite BioPharma Ltd.. Started Jul 2009; status: completed.
02
Drugs
namodenoson
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00790673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790673.